By Drew Armstrong, Bloomberg |
November 1, 2012
Pfizer Inc., the world’s biggest drugmaker, narrowed its 2012 forecast after reporting third- quarter earnings that met analyst estimates and sales that fell short of expectations.
Commodity bears crawling out?
How many Apples in a bitcoin?
Singapore Exchange to launch yen futures
Will Treasury play hardball with inversions?
How low can corn go?
Natural gas at an inflection point?
Protection from market spikes